Dr Suzi Cottrell is highly experienced in the use and application of health technology assessment methodologies, including systematic review, meta-analysis, patient preference using discrete choice experiment, health state utility valuation, conduct of health-related quality of life studies and other qualitative/quantitative health care research. Suzi has contributed to numerous reimbursement applications for drugs, medical devices and diagnostic tests both in Australia and New Zealand as well as the UK and several other European countries. Her experience covers many therapeutic areas including: mental health, oncology, infectious diseases, cardiovascular disease, type 2 diabetes, chronic kidney disease, rheumatoid arthritis, psoriasis and asthma.
In her previous role, Suzi worked as a senior consultant and manager in health economics and outcomes research in the UK. Formerly, she was engaged in toxicology research and chemical/drug safety assessment, within both academic and pharmaceutical industry settings, and for the UK Department of Health. She graduated with an honours degree in biochemistry from the University of Surrey, where she also completed her PhD studies in xenobiotic metabolism. Suzi took up her position at THEMA in 2008.